(Q33502866)

27 July 2017

title

All trans retinoic acid with low dose cytosine arabinoside in the treatment of myelodysplastic syndrome (English)

1 reference

27 July 2017

1 reference

myelodysplastic syndrome

1 reference

1 reference

Nair R

1

1 reference

27 July 2017

Nair CN

series ordinal

2

1 reference

27 July 2017

Advani SH

series ordinal

3

1 reference

27 July 2017

publication date

1 March 1998

1 reference

27 July 2017

1 reference

27 July 2017

volume

29

1 reference

27 July 2017

issue

1-2

1 reference

27 July 2017

page(s)

187-192

1 reference

The myelodysplastic syndromes: current approaches to therapy

27 July 2017

cites work

1 reference

https://api.crossref.org/works/10.3109%2F10428199809058394

Therapy of 'high risk' myelodysplastic syndromes with an association of low-dose Ara-C, retinoic acid and 1,25-dihydroxyvitamin D3

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199809058394

Proposals for the classification of the myelodysplastic syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199809058394

Retinoic acid-induced granulocytic differentiation of HL-60 myeloid leukemia cells is mediated directly through the retinoic acid receptor (RAR-alpha).

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199809058394

Saturation analysis of cellular retinoid binding proteins: application to retinoic acid resistant human neuroblastoma cells and to human tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199809058394

Overexpression of the cellular retinoic acid binding protein-I (CRABP-I) results in a reduction in differentiation-specific gene expression in F9 teratocarcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199809058394

Differentiation therapy of myelodysplastic syndromes with retinoic acid

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199809058394

The "Retinoic Acid Syndrome" in Acute Promyelocytic Leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199809058394

A randomized trial of 13-cis retinoic acid with or without cytosine arabinoside in patients with the myelodysplastic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199809058394

10.3109/10428199809058394

21 January 2018

Identifiers

DOI

1 reference

27 July 2017

1 reference